what dose of semaglutide is needed for weight loss Understanding Dosage: Key Information Semaglutide Dosage Guide for Weight

Her pulse increased from 54 to 70 bpm

Sometimes yes for diabetes, often no for weight management

Semaglutide GLP-1 serves as the active ingredient in both Ozempic and Wegovy, wherein Ozempic is predominantly used for the treatment of type 2 diabetes, and Wegovy is approved for weight management

On Monday, Novo Nordisk said it is suing Hims, asking the court to permanently ban the company from selling compounded versions of its drugs that infringe on Novos patents

- Pitching products: why its key to answer why now

Not just chemistry, but biology, precision design, and regulatory depth are now becoming essential to compete in this space." Hari Kiran Chereddi, MD & CEO, HRV Pharma and NHG Pharma GLP-1 Patent Expiry Timeline and Market Dynamics The market opportunity is defined by several critical factors: Patent Expiration: Semaglutide's key patents expire globally by early 2026 Market Growth: Demand for obesity and diabetes treatments growing 12-14% year-over-year Healthcare Savings: Indian companies can save global healthcare systems billions through cost-effective alternatives Regulatory Access: Opportunities to develop biosimilars or complex generics for US and EU markets Beyond Cost Competition: Value-Based Differentiation The competitive landscape for GLP-1 drugs extends beyond traditional cost advantages that have historically defined Indian pharmaceutical success